Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The novel ghrelin receptor inverse agonist PF-5190457 administered with alcohol: preclinical safety experiments and a phase 1b human laboratory study.
Lee MR, Tapocik JD, Ghareeb M, Schwandt ML, Dias AA, Le AN, Cobbina E, Farinelli LA, Bouhlal S, Farokhnia M, Heilig M, Akhlaghi F, Leggio L. Lee MR, et al. Among authors: cobbina e. Mol Psychiatry. 2020 Feb;25(2):461-475. doi: 10.1038/s41380-018-0064-y. Epub 2018 May 4. Mol Psychiatry. 2020. PMID: 29728704 Free PMC article. Clinical Trial.
Endocrine effects of the novel ghrelin receptor inverse agonist PF-5190457: Results from a placebo-controlled human laboratory alcohol co-administration study in heavy drinkers.
Lee MR, Farokhnia M, Cobbina E, Saravanakumar A, Li X, Battista JT, Farinelli LA, Akhlaghi F, Leggio L. Lee MR, et al. Among authors: cobbina e. Neuropharmacology. 2020 Jun 15;170:107788. doi: 10.1016/j.neuropharm.2019.107788. Epub 2019 Sep 23. Neuropharmacology. 2020. PMID: 31557492 Free PMC article. Clinical Trial.
Neuroendocrine Response to Exogenous Ghrelin Administration, Combined With Alcohol, in Heavy-Drinking Individuals: Findings From a Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study.
Farokhnia M, Abshire KM, Hammer A, Deschaine SL, Saravanakumar A, Cobbina E, You ZB, Haass-Koffler CL, Lee MR, Akhlaghi F, Leggio L. Farokhnia M, et al. Among authors: cobbina e. Int J Neuropsychopharmacol. 2021 Jul 14;24(6):464-476. doi: 10.1093/ijnp/pyab004. Int J Neuropsychopharmacol. 2021. PMID: 33560411 Free PMC article. Clinical Trial.
[No title available]
[No authors listed] [No authors listed] PMID: 31963099
Decreasing ICU and Hospital Length of Stay through a Standardized Respiratory Therapist-driven Electronic Clinical Care Pathway for Status Asthmaticus.
Lopez M, Wilson M, Cobbina E, Kaufman D, Fluitt J, Grainger M, Ruiz R, Abudukadier G, Tiras M, Carlson B, Spaid J, Falsone K, Cocjin I, Moretti A, Vercio C, Tinsley C, Chandnani HK, Samayoa C, Cianci C, Pappas J, Chang NY. Lopez M, et al. Among authors: cobbina e. Pediatr Qual Saf. 2023 Dec 5;8(6):e697. doi: 10.1097/pq9.0000000000000697. eCollection 2023 Nov-Dec. Pediatr Qual Saf. 2023. PMID: 38058471 Free PMC article.
A systems pharmacology model for gene therapy in sickle cell disease.
Zheng B, Wille L, Peppel K, Hagen D, Matteson A, Ahlers J, Schaff J, Hua F, Yuraszeck T, Cobbina E, Apgar JF, Burke JM, Roberts J, Das R. Zheng B, et al. Among authors: cobbina e. CPT Pharmacometrics Syst Pharmacol. 2021 Jul;10(7):696-708. doi: 10.1002/psp4.12638. Epub 2021 Jun 17. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 34139105 Free PMC article.